SVP, Pfizer Oncology US Lead 

Diego Sacristan is Senior Vice President, Pfizer’s Oncology US lead and a member of the Global Oncology Leadership Team.

In this role, Diego leads an industry-leading portfolio of more than 20 approved innovative cancer medicines and biosimilars across more than 30 indications in the US, with a focus in breast cancer, genitourinary cancer, hematology and precision medicine. 

Prior to this role, Diego served as Regional President for International Developed Markets (Europe, Japan, Korea, Australia/NZ, Russia, Turkey and Israel). Diego started his career with Pfizer in Spain and has been with the company for 18 years in a number of roles spanning a broad set of responsibilities across Europe, Latin America, Africa, Middle East and Asia. 

Diego leads Pfizer’s Latino Colleague Council, a group that provides networking, leadership training and mentoring programs, as well as opportunities to celebrate the ethnic and cultural diversity of Pfizer’s Latino community.

Diego received both a bachelor’s and master’s degree in Economics and Management from the Universidad Complutense in Madrid. He also completed the Advance Management Program (PDD) from IESE Business School. 


We are ViiV Healthcare: 100% dedicated to HIV medicines and research and focused on people living with HIV and AIDS.

Together we are engaged in the HIV response throughout the world, supported by a team of over 1,100 dedicated ViiV Healthcare staff working across the globe.

Discover more about who we are, the work we do and what we're doing to advance HIV science, support the delivery of HIV treatment and care; and work with partners to address the stigma and discrimination faced by people living with HIV.